Envoy Medical Inc
COCH1.435USD
-0.010-0.69%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
30.88MMarket Cap
LossP/E TTM
Envoy Medical Inc
1.435
-0.010-0.69%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Total revenue
-22.03%46.00K
-55.79%42.00K
-30.00%56.00K
7.94%68.00K
-24.36%59.00K
375.00%95.00K
40.35%80.00K
6.78%63.00K
-22.77%78.00K
--20.00K
--57.00K
--59.00K
--101.00K
Revenue
-22.03%46.00K
-55.79%42.00K
-30.00%56.00K
7.94%68.00K
-24.36%59.00K
375.00%95.00K
40.35%80.00K
6.78%63.00K
-22.77%78.00K
--20.00K
--57.00K
--59.00K
--101.00K
Cost of revenue
47.71%226.00K
-32.91%157.00K
-1.06%187.00K
-26.43%245.00K
-47.96%153.00K
-61.64%234.00K
78.30%189.00K
52.75%333.00K
38.03%294.00K
--610.00K
--106.00K
--218.00K
--213.00K
Operating expenses
4.25%5.15M
-33.03%4.57M
45.17%5.03M
8.47%4.93M
28.42%4.94M
133.01%6.82M
86.99%3.46M
101.64%4.54M
101.41%3.85M
--2.93M
--1.85M
--2.25M
--1.91M
R&D expenses
16.44%2.75M
-19.12%2.47M
49.03%2.76M
30.79%2.59M
30.46%2.36M
210.47%3.06M
97.86%1.85M
45.55%1.98M
72.94%1.81M
--984.00K
--935.00K
--1.36M
--1.05M
Depreciation, depletion, and amortization
79.41%61.00K
0.00%48.00K
68.97%49.00K
44.83%42.00K
25.93%34.00K
84.62%48.00K
31.82%29.00K
107.14%29.00K
107.69%27.00K
--26.00K
--22.00K
--14.00K
--13.00K
Operating profit
-4.57%-5.11M
32.71%-4.52M
-46.94%-4.97M
-8.48%-4.86M
-29.51%-4.88M
-131.35%-6.72M
-88.47%-3.38M
-104.19%-4.48M
-108.34%-3.77M
---2.91M
---1.80M
---2.19M
---1.81M
Net non-operating interest income (expenses)
Non-operating interest expense
1275.00%495.00K
--384.00K
--264.00K
--132.00K
--36.00K
----
----
----
----
----
----
----
----
Special income (expenses)
146.03%615.00K
-80.70%331.00K
-115.03%-737.00K
111.92%1.04M
85.75%-1.34M
120.03%1.71M
754.01%4.90M
-1014.08%-8.77M
-15528.33%-9.38M
---8.56M
--574.00K
--959.00K
---60.00K
Other non-operating income (expenses)
21.43%-11.00K
-136.28%-41.00K
-67.39%15.00K
--0.00
86.67%-14.00K
1512.50%113.00K
139.32%46.00K
100.00%0.00
-10400.00%-105.00K
---8.00K
---117.00K
---1.00K
---1.00K
Income before tax
20.29%-5.00M
5.66%-4.62M
-481.32%-5.96M
70.20%-3.95M
52.69%-6.27M
57.35%-4.89M
216.73%1.56M
-971.68%-13.25M
-608.34%-13.25M
---11.48M
---1.34M
---1.24M
---1.87M
Income tax
----
--0.00
----
----
----
--0.00
----
----
----
----
----
----
----
Income after tax
20.29%-5.00M
5.66%-4.62M
-481.32%-5.96M
70.20%-3.95M
52.69%-6.27M
57.35%-4.89M
216.73%1.56M
-971.68%-13.25M
-608.34%-13.25M
---11.48M
---1.34M
---1.24M
---1.87M
Net income from continuous operations
20.29%-5.00M
5.66%-4.62M
-481.32%-5.96M
70.20%-3.95M
52.69%-6.27M
57.35%-4.89M
216.73%1.56M
-971.68%-13.25M
-608.34%-13.25M
---11.48M
---1.34M
---1.24M
---1.87M
Net income attributable to controlling interests
18.32%-6.24M
-23.09%-7.69M
-639.71%-7.34M
61.36%-5.31M
44.48%-7.63M
45.60%-6.24M
201.57%1.36M
-691.82%-13.75M
-480.05%-13.75M
---11.48M
---1.34M
---1.74M
---2.37M
Preferred share dividend
-9.30%1.24M
127.43%3.07M
579.80%1.38M
173.00%1.36M
173.00%1.36M
--1.35M
--203.00K
0.00%500.00K
0.00%500.00K
----
----
--500.00K
--500.00K
Net income attributable to common shareholders
18.32%-6.24M
-23.09%-7.69M
-639.71%-7.34M
61.36%-5.31M
44.48%-7.63M
45.60%-6.24M
201.57%1.36M
-691.82%-13.75M
-480.05%-13.75M
---11.48M
---1.34M
---1.74M
---2.37M
Basic earnings per share
28.77%-0.29
-40.99%-0.47
-381.02%-0.37
61.45%-0.27
41.65%-0.41
43.19%-0.33
294.41%0.13
-691.80%-0.70
-480.05%-0.70
---0.59
---0.07
---0.09
---0.12
Diluted earnings per share
28.77%-0.29
-40.99%-0.47
-398.89%-0.37
61.45%-0.27
41.65%-0.41
43.19%-0.33
282.79%0.13
-691.80%-0.70
-480.05%-0.70
---0.59
---0.07
---0.09
---0.12
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
